EFETTI DEL MEXILETINE PER VIA VENOSA SULLA PERFORMANCE CARDIACA

Translated title of the contribution: The effects of intravenous mexiletine on cardiac performance

G. Ferro, V. Santinelli, M. G. Tari

Research output: Contribution to journalArticle

Abstract

The effects of intravenous Mexiletine (Ko1173) on cardiac performance has been studied in 20 patients affected by myocardiosclerosis (10 patients classified in the 1st or 2nd NYHA classes, 10 cases in the 3rd or 4th ones). Mexiletine (1.5 mg/Kg) was given intravenously over a period of 1 minute. The effect on myocardial function has been evaluated by means of the systolic time intervals (STI). The drug caused non-significant changes of the left ventrical ejection time (LVET); on the contrary, it caused a significant increase of the pre-ejection period (PEP), isometric contraction time (ICT) and the PEP/ LVET ratio. These alteration became evident after 5-10 minutes and disappeared about 30 minutes after administration of the drug.

Translated title of the contributionThe effects of intravenous mexiletine on cardiac performance
Original languageItalian
Pages (from-to)502-506
Number of pages5
JournalGiornale Italiano di Cardiologia
Volume9
Issue number5
Publication statusPublished - 1979

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The effects of intravenous mexiletine on cardiac performance'. Together they form a unique fingerprint.

  • Cite this